Literature DB >> 16215733

Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein.

Chris Druar1, Surinder S Saini, Meredith A Cossitt, Fei Yu, Xiangguo Qiu, Thomas W Geisbert, Steven Jones, Peter B Jahrling, Donald I H Stewart, Erik J Wiersma.   

Abstract

The cynomolgus macaque, Macaca fascicularis, is frequently used in immunological and other biomedical research as a model for man; understanding it's antibody repertoire is, therefore, of fundamental interest. The expressed variable-region gene repertoire of a single M. fascicularis, which was immune to the Ebola virus, was studied. Using 5' rapid amplification of cDNA ends with immunoglobulin (Ig)G-specific primers, we obtained 30 clones encoding full-length variable, diversity, and joining domains. Similar to the human V(H) repertoire, the M. fascicularis repertoire utilized numerous immunoglobulin heavy variable (IGHV) gene fragments, with the V(H)3 (41%), V(H)4 (39%), and V(H)1 (14%) subgroups used more frequently than the V(H)5 (3.9%) or V(H)7 (1.7%) subgroups. Diverse immunoglobulin heavy joining (IGHJ) fragments also appeared to be utilized, including a putative homolog of JH5beta gene segment identified in the related species Macaca mulatta, Rhesus macaque, but not in humans. Although the diverse V region genes in the IgG antibody repertoire of M. fascicularis had likely undergone somatic hypermutations (SHMs), they nevertheless showed high nucleotide identity with the corresponding human germline genes, 80-89% for IGHV and 72-92% for IGHJ. M. fascicularis and human V(H) genes were also similar in other aspects: length of complementarity-determining regions and framework regions, and distribution of consensus sites for SHMs. Finally, we demonstrated that monoclonal antibodies (mAbs) specific for an Ebola protein could be obtained from M. fascicularis tissue samples by phage display technology. In summary, the study provides new insight into the M. fascicularis V region gene repertoire and further supports the idea that macaque-derived mAbs may be of therapeutic value to humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215733     DOI: 10.1007/s00251-005-0047-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  38 in total

1.  DNA polymerases in immunity: profiting from errors.

Authors:  U Storb
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

2.  A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions.

Authors:  Glenn Soltes; Heather Barker; Kristine Marmai; Elaine Pun; Amy Yuen; Erik J Wiersma
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

3.  Conservation of the most JH proximal Ig VH gene segment (VHVI) throughout primate evolution.

Authors:  K Meek; T Eversole; J D Capra
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

4.  IMGT, the international ImMunoGeneTics database.

Authors:  M P Lefranc; V Giudicelli; C Ginestoux; J Bodmer; W Müller; R Bontrop; M Lemaitre; A Malik; V Barbié; D Chaume
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

5.  Evolution of the structural repertoire of the human V(H) and Vkappa germline genes.

Authors:  E Vargas-Madrazo; F Lara-Ochoa; M C Ramirez-Benites; J C Almagro
Journal:  Int Immunol       Date:  1997-12       Impact factor: 4.823

6.  Does base composition help predispose the complementarity-determining regions of antibodies to hypermutation?

Authors:  E A Padlan
Journal:  Mol Immunol       Date:  1997-08       Impact factor: 4.407

7.  The imprint of somatic hypermutation on the repertoire of human germline V genes.

Authors:  I M Tomlinson; G Walter; P T Jones; P H Dear; E L Sonnhammer; G Winter
Journal:  J Mol Biol       Date:  1996-03-15       Impact factor: 5.469

Review 8.  Assembly of IgH CDR3: mechanism, regulation, and influence on antibody diversity.

Authors:  L VanDyk; K Meek
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

9.  Structural conservation of hypervariable regions in immunoglobulins evolution.

Authors:  S Barré; A S Greenberg; M F Flajnik; C Chothia
Journal:  Nat Struct Biol       Date:  1994-12

10.  Analysis of immunoglobulin VH gene repertoire by an anchored PCR-ELISA.

Authors:  L Z Rassenti; H Kohsaka; T J Kipps
Journal:  Ann N Y Acad Sci       Date:  1995-09-29       Impact factor: 5.691

View more
  9 in total

1.  Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

Authors:  Jeffrey E Lee; Ana Kuehne; Dafna M Abelson; Marnie L Fusco; Mary Kate Hart; Erica Ollmann Saphire
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

2.  Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.

Authors:  Jeffrey E Lee; Marnie L Fusco; Dafna M Abelson; Ann J Hessell; Dennis R Burton; Erica Ollmann Saphire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-10-22

3.  Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description.

Authors:  Guo-Yun Yu; Suzanne Mate; Karla Garcia; Michael D Ward; Ernst Brueggemann; Matthew Hall; Tara Kenny; Mariano Sanchez-Lockhart; Marie-Paule Lefranc; Gustavo Palacios
Journal:  Immunogenetics       Date:  2016-05-27       Impact factor: 2.846

4.  Construction and characterization of VL-VH tail-parallel genetically engineered antibodies against staphylococcal enterotoxins.

Authors:  Xianzhi He; Lei Zhang; Pengchong Liu; Li Liu; Hui Deng; Jinhai Huang
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

5.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 6.  Exploitation of glycosylation in enveloped virus pathobiology.

Authors:  Yasunori Watanabe; Thomas A Bowden; Ian A Wilson; Max Crispin
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-05-20       Impact factor: 3.770

Review 7.  The secret life of viral entry glycoproteins: moonlighting in immune evasion.

Authors:  Jonathan D Cook; Jeffrey E Lee
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

8.  Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates.

Authors:  Tal Noy-Porat; Ronit Rosenfeld; Naomi Ariel; Eyal Epstein; Ron Alcalay; Anat Zvi; Chanoch Kronman; Arie Ordentlich; Ohad Mazor
Journal:  Toxins (Basel)       Date:  2016-03-03       Impact factor: 4.546

Review 9.  Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries.

Authors:  Obinna Ubah; Soumya Palliyil
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.